Karim Fizazi, MD, PhD, on Whether or How to Combine Prostate Cancer Treatments

Posted: Monday, June 7, 2021

Karim Fizazi, MD, PhD, of Institut Gustave Roussy, discusses the clinical implications of findings from the PEACE1 study, which explored the use of abiraterone added to androgen deprivation therapy and docetaxel.